Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis

Abstract Background Radiographic progression and course of inflammation over 2 years in patients with non-radiographic axial spondyloarthritis (nr-axSpA) from the phase 3, randomized, PREVENT study are reported here. Methods In the PREVENT study, adult patients fulfilling the Assessment of SpondyloA...

Descrición completa

Detalles Bibliográficos

Principais autores:	Juergen Braun, Ricardo Blanco, Helena Marzo-Ortega, Lianne S. Gensler, Filip Van den Bosch, Stephen Hall, Hideto Kameda, Denis Poddubnyy, Marleen van de Sande, Désirée van der Heijde, Tingting Zhuang, Anna Stefanska, Aimee Readie, Hanno B. Richards, Atul Deodhar
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-05-01
Series:	Arthritis Research & Therapy
Assuntos:	Axial spondyloarthritis Non-radiographic axial spondyloarthritis Nr-axSpA Secukinumab X-ray Radiograph
Acceso en liña:	https://doi.org/10.1186/s13075-023-03051-5
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!